SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer

Table 1 Analysis of 56 basal-like and triple-negative breast cancer tumor samples

EGFR epidermal growth factor receptor, IHC immunohistochemistry, SHP2 Src homology phosphotyrosyl phosphatase 2
A total of 56 basal-like and triple-negative breast cancer tumor samples were analyzed for SHP2 and EGFR by immunohistochemistry as described in Materials and methods. Samples that showed 3+ and 2+ expression levels were considered as positive for elevated expression of SHP2 and EGFR

ISSN: 1465-542X